Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when TNGX files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsTango Therapeutics holds routine annual meeting, elects two directors and ratifies auditor
Filed June 4, 2026 · Period ending June 4, 2026 · ~1 min read
Key Changes
-
low
Shareholders elected Malte Peters, M.D. and Mace Rothenberg, M.D. as Class II directors to serve until 2029, with both receiving strong majority support.
Item 5.07 verify on EDGAR → -
low
PricewaterhouseCoopers was ratified as independent auditor for fiscal 2026 with over 99% approval from voting shareholders.
Item 5.07 verify on EDGAR → -
low
Executive compensation received 98% shareholder approval in non-binding advisory vote, indicating strong support for management pay practices.
Item 5.07 verify on EDGAR → -
low
Filing confirms prior disclosure that director Kanishka Pothula resigned from the Board on May 13, 2026, with no disagreements on company operations or policies.
Item 5.07 verify on EDGAR →
Summary
Tango Therapeutics filed a routine 8-K documenting results from its 2026 annual shareholder meeting held June 4. The meeting covered standard corporate housekeeping items with no surprises. Two directors were elected to three-year terms with solid support, the audit firm was reappointed, and executive pay received strong approval.
For retail investors, this filing signals business as usual with no governance concerns. The high approval rates across all proposals suggest shareholders are generally satisfied with board composition and management. The confirmation of director Pothula's May resignation adds no new information beyond what was previously disclosed.
Watch for the company's proxy statement later this year for details on any board composition changes or executive compensation adjustments heading into 2027. Otherwise, this is purely administrative with no immediate investment implications.
Section-by-Section Diff
Event · Item 5.07 — Submission of Matters to a Vote of Security Holders
Tango held its 2026 annual meeting, electing two Class II directors and ratifying PwC as auditor; prior director resignation noted.
Show 4 minor / wording changes
Added in current filing · verify on EDGAR →
Malte Peters, M.D. and Mace Rothenberg, M.D. were duly elected to the Company’s Board as Class II directors.
Two Class II directors were elected at the annual meeting to serve until 2029. Malte Peters received 98,188,796 votes for with 17,623,596 withheld, and Mace Rothenberg received 92,476,172 votes for with 23,336,220 withheld. Both directors were successfully elected with majority support.
Added in current filing · verify on EDGAR →
As previously disclosed on a Current Report on Form 8-K filed by the Company on May 13, 2026, Kanishka Pothula notified the Board that he had resigned from his role as a director of the Board and as a member of the Nominating and Corporate Governance Committee, effective May 13, 2026, prior to the Annual Meeting.
Director Kanishka Pothula resigned from the Board and Nominating Committee effective May 13, 2026, before the annual meeting. The filing confirms his resignation was not due to any disagreement with the company on operations, practices, or policies. This was previously disclosed in a separate 8-K.
Added in current filing · verify on EDGAR →
The selection of PricewaterhouseCoopers, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified.
Shareholders ratified PricewaterhouseCoopers as the independent auditor for fiscal 2026 with 131,097,992 votes for, 73,823 against, and 26,266 abstentions. This is a routine annual vote confirming the audit firm selection.
Added in current filing · verify on EDGAR →
The Company’s stockholders approved the non-binding, advisory vote on the compensation of the Company’s named executive officers.
Shareholders approved executive compensation on an advisory basis with 113,915,877 votes for, 1,855,838 against, and 40,677 abstentions. This non-binding say-on-pay vote received approximately 98% support from voting shareholders.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 5, 2026 · How we verify